Advertisement
Screener

NeoGenomics, Inc. (NEO) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

2.9 / 5 stars · 42/72 Roast Me

NeoGenomics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

NeoGenomics, Inc. (NEO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 993.76 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-07-28

  • NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 586.08K shares, a 6.42% decline year-over-year.
  • NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 407.68K shares, a 41.65% increase year-over-year.
  • NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 208.49K shares, a 679.82% increase year-over-year.
  • NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 341.81K shares, a 216.25% increase year-over-year.
  • NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 1.46M shares, a 249.39% increase from fiscal 2024.
  • NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 419.14K shares, a 66.04% decline from fiscal 2023.
  • NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 1.23M shares, a 46.14% decline from fiscal 2022.
  • NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 2.29M shares, a 234.92% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed
2026-06-30586.08K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28
993.76K shares
10-Q · filed 2026-07-28
1.20M shares
derived: sum of 3 quarters · filed 2026-07-28
1.54M shares
derived: sum of 4 quarters · filed 2026-07-28
2026-03-31407.68K shares
10-Q · filed 2026-04-28
616.17K shares
derived: sum of 2 quarters · filed 2026-04-28
957.98K shares
derived: sum of 3 quarters · filed 2026-04-28
1.58M shares
derived: sum of 4 quarters · filed 2026-04-28
2025-12-31208.49K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
550.30K shares
derived: sum of 2 quarters · filed 2026-02-17
1.18M shares
derived: sum of 3 quarters · filed 2026-02-17
1.46M shares
10-K · filed 2026-02-17
2025-09-30341.81K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
968.13K shares
derived: sum of 2 quarters · filed 2025-10-28
1.26M shares
10-Q · filed 2025-10-28
1.28M shares
derived: sum of 4 quarters · filed 2026-02-17
2025-06-30626.32K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29
914.13K shares
10-Q · filed 2025-07-29
940.87K shares
derived: sum of 3 quarters · filed 2026-02-17
1.05M shares
derived: sum of 4 quarters · filed 2026-02-17
2025-03-31287.81K shares
10-Q · filed 2025-04-29
314.55K shares
derived: sum of 2 quarters · filed 2026-02-17
422.63K shares
derived: sum of 3 quarters · filed 2026-02-17
676.57K shares
derived: sum of 4 quarters · filed 2026-02-17
2024-12-3126.74K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
134.82K shares
derived: sum of 2 quarters · filed 2026-02-17
388.75K shares
derived: sum of 3 quarters · filed 2026-02-17
419.14K shares
10-K · filed 2026-02-17
2024-09-30108.08K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05
362.02K shares
derived: sum of 2 quarters · filed 2024-11-05
392.40K shares
10-Q · filed 2024-11-05
484.16K shares
derived: sum of 4 quarters · filed 2026-02-17
2024-06-30253.94K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30
284.32K shares
10-Q · filed 2024-07-30
376.08K shares
derived: sum of 3 quarters · filed 2026-02-17
699.99K shares
derived: sum of 4 quarters · filed 2026-02-17
2024-03-3130.38K shares
10-Q · filed 2024-04-30
122.14K shares
derived: sum of 2 quarters · filed 2026-02-17
446.05K shares
derived: sum of 3 quarters · filed 2026-02-17
916.89K shares
derived: sum of 4 quarters · filed 2026-02-17
2023-12-3191.76K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
415.67K shares
derived: sum of 2 quarters · filed 2026-02-17
886.51K shares
derived: sum of 3 quarters · filed 2026-02-17
1.23M shares
10-K · filed 2026-02-17
2023-09-30323.91K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06
794.75K shares
derived: sum of 2 quarters · filed 2023-11-06
1.14M shares
10-Q · filed 2023-11-06
1.68M shares
derived: sum of 4 quarters · filed 2025-02-18
2023-06-30470.84K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
818.56K shares
10-Q · filed 2023-08-08
1.35M shares
derived: sum of 3 quarters · filed 2025-02-18
1.79M shares
derived: sum of 4 quarters · filed 2025-02-18
2023-03-31347.72K shares
10-Q · filed 2023-05-09
880.49K shares
derived: sum of 2 quarters · filed 2025-02-18
1.32M shares
derived: sum of 3 quarters · filed 2025-02-18
1.89M shares
derived: sum of 4 quarters · filed 2025-02-18
2022-12-31532.77K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18
975.54K shares
derived: sum of 2 quarters · filed 2025-02-18
1.54M shares
derived: sum of 3 quarters · filed 2025-02-18
2.29M shares
10-K · filed 2025-02-18
2022-09-30442.78K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
1.01M shares
derived: sum of 2 quarters · filed 2022-11-08
1.76M shares
10-Q · filed 2022-11-08
2.22M shares
derived: sum of 4 quarters · filed 2024-02-20
2022-06-30568.84K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
1.32M shares
10-Q · filed 2022-08-09
1.77M shares
derived: sum of 3 quarters · filed 2024-02-20
1.80M shares
derived: sum of 4 quarters · filed 2024-02-20
2022-03-31747.27K shares
10-Q · filed 2022-05-09
1.21M shares
derived: sum of 2 quarters · filed 2024-02-20
1.23M shares
derived: sum of 3 quarters · filed 2024-02-20
1.38M shares
derived: sum of 4 quarters · filed 2024-02-20
2021-12-31457.83K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20
484.09K shares
derived: sum of 2 quarters · filed 2024-02-20
629.94K shares
derived: sum of 3 quarters · filed 2024-02-20
684.24K shares
10-K · filed 2024-02-20
2021-09-3026.26K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
172.12K shares
derived: sum of 2 quarters · filed 2021-11-04
226.41K shares
10-Q · filed 2021-11-04
230.25K shares
derived: sum of 4 quarters · filed 2023-02-24
2021-06-30145.85K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
200.15K shares
10-Q · filed 2021-08-09
203.98K shares
derived: sum of 3 quarters · filed 2023-02-24
209.49K shares
derived: sum of 4 quarters · filed 2023-02-24
2021-03-3154.30K shares
10-Q · filed 2021-05-06
58.13K shares
derived: sum of 2 quarters · filed 2023-02-24
63.64K shares
derived: sum of 3 quarters · filed 2023-02-24
70.09K shares
derived: sum of 4 quarters · filed 2023-02-24
2020-12-313.83K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24
9.35K shares
derived: sum of 2 quarters · filed 2023-02-24
15.79K shares
derived: sum of 3 quarters · filed 2023-02-24
67.00K shares
10-K · filed 2023-02-24
2020-09-305.51K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
11.96K shares
derived: sum of 2 quarters · filed 2020-10-29
63.17K shares
10-Q · filed 2020-10-29
69.17K shares
derived: sum of 4 quarters · filed 2022-02-25
2020-06-306.45K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
57.66K shares
10-Q · filed 2020-07-31
63.66K shares
derived: sum of 3 quarters · filed 2022-02-25
199.96K shares
derived: sum of 4 quarters · filed 2022-02-25
2020-03-3151.21K shares
10-Q · filed 2020-04-29
57.21K shares
derived: sum of 2 quarters · filed 2022-02-25
193.51K shares
derived: sum of 3 quarters · filed 2022-02-25
229.64K shares
derived: sum of 4 quarters · filed 2022-02-25
2019-12-316.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
142.30K shares
derived: sum of 2 quarters · filed 2022-02-25
178.43K shares
derived: sum of 3 quarters · filed 2022-02-25
180.93K shares
10-K · filed 2022-02-25
2019-09-30136.30K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
172.43K shares
derived: sum of 2 quarters · filed 2019-11-13
174.93K shares
10-Q · filed 2019-11-13
226.68K shares
derived: sum of 4 quarters · filed 2021-02-25
2019-06-3036.13K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
38.63K shares
10-Q · filed 2019-08-07
90.38K shares
derived: sum of 3 quarters · filed 2021-02-25
403.13K shares
derived: sum of 4 quarters · filed 2021-02-25
2019-03-312.50K shares
10-Q · filed 2019-05-08
54.25K shares
derived: sum of 2 quarters · filed 2021-02-25
367.00K shares
derived: sum of 3 quarters · filed 2021-02-25
380.00K shares
derived: sum of 4 quarters · filed 2021-02-25
2018-12-3151.75K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
364.50K shares
derived: sum of 2 quarters · filed 2021-02-25
377.50K shares
derived: sum of 3 quarters · filed 2021-02-25
390.00K shares
10-K · filed 2021-02-25
2018-09-30312.75K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
325.75K shares
derived: sum of 2 quarters · filed 2018-11-06
338.25K shares
10-Q · filed 2018-11-06
475.42K shares
derived: sum of 4 quarters · filed 2020-02-28
2018-06-3013.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06
25.50K shares
10-Q · filed 2018-08-06
162.66K shares
derived: sum of 3 quarters · filed 2020-02-28
319.75K shares
derived: sum of 4 quarters · filed 2020-02-28
2018-03-3112.50K shares
10-Q · filed 2018-05-08
149.67K shares
derived: sum of 2 quarters · filed 2020-02-28
306.75K shares
derived: sum of 3 quarters · filed 2020-02-28
318.00K shares
derived: sum of 4 quarters · filed 2020-02-28
2017-12-31137.17K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
294.25K shares
derived: sum of 2 quarters · filed 2020-02-28
305.50K shares
derived: sum of 3 quarters · filed 2020-02-28
347.51K shares
10-K · filed 2020-02-28
2017-09-30157.08K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13
168.33K shares
derived: sum of 2 quarters · filed 2017-11-13
210.35K shares
10-Q · filed 2017-11-13
276.59K shares
derived: sum of 4 quarters · filed 2019-02-26
2017-06-3011.25K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07
53.27K shares
10-Q · filed 2017-08-07
119.51K shares
derived: sum of 3 quarters · filed 2019-02-26
119.51K shares
derived: sum of 4 quarters · filed 2019-02-26
2017-03-3142.02K shares
10-Q · filed 2017-05-09
108.26K shares
derived: sum of 2 quarters · filed 2019-02-26
108.26K shares
derived: sum of 3 quarters · filed 2019-02-26
226.88K shares
derived: sum of 4 quarters · filed 2019-02-26
2016-12-3166.25K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
66.25K shares
derived: sum of 2 quarters · filed 2019-02-26
184.86K shares
derived: sum of 3 quarters · filed 2019-02-26
324.40K shares
10-K · filed 2019-02-26
2016-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
118.61K shares
derived: sum of 2 quarters · filed 2016-11-07
258.15K shares
10-Q · filed 2016-11-07
258.15K shares
derived: sum of 4 quarters · filed 2018-03-13
2016-06-30118.61K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
258.15K shares
10-Q · filed 2016-08-05
258.15K shares
derived: sum of 3 quarters · filed 2018-03-13
265.65K shares
derived: sum of 4 quarters · filed 2018-03-13
2016-03-31139.54K shares
10-Q · filed 2016-05-10
139.54K shares
derived: sum of 2 quarters · filed 2018-03-13
147.04K shares
derived: sum of 3 quarters · filed 2018-03-13
152.04K shares
derived: sum of 4 quarters · filed 2018-03-13
2015-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13
7.50K shares
derived: sum of 2 quarters · filed 2018-03-13
12.50K shares
derived: sum of 3 quarters · filed 2018-03-13
12.50K shares
10-K · filed 2018-03-13
2015-09-307.50K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
12.50K shares
derived: sum of 2 quarters · filed 2015-11-06
12.50K shares
10-Q · filed 2015-11-06
2015-06-305.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31
5.00K shares
10-Q · filed 2015-07-31
2015-03-310.00 shares
10-Q · filed 2015-05-11
2014-12-3186.38K shares
10-K · filed 2017-03-14
2013-12-3128.92K shares
10-K · filed 2016-04-18
2012-12-31102.75K shares
10-K · filed 2015-03-03
102.75K shares
10-K · filed 2013-02-21
2011-12-31827.37K shares
10-K · filed 2014-02-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
20/20 Biolabs, Inc. (AIDX)United States$0.005B